PET Imaging Study of α7 and α4β2-nAChR in Schizophrenia
NCT05462340
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
117
Enrollment
OTHER
Sponsor class
Stopped
Study recruitment milestones were not met.
Conditions
Schizophrenia
Interventions
DRUG:
[18F]ASEM
DRUG:
[18F]AZAN
Sponsor
Washington University School of Medicine